Therapeutics Acquisition Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| Q2 2020 | 0 | -19.36K | |
|---|---|---|---|
| Q1 2021 | 0 | -1.39M | |
| Q2 2021 | 0 | -14.26M |
RACA Income Statement (Q2 2020 – Q2 2021)
| Q2 2021 | Q1 2021 | Q2 2020 | |
|---|---|---|---|
Revenue | |||
Revenue | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 |
Operating exp. | |||
Research and development | 10.97M | 0 | 0 |
Selling and marketing | 0 | 0 | 0 |
Total operating expenses | 14.38M | 1.40M | 19.36K |
Operating income | -8.65M | -1.40M | -19.36K |
Other income (expenses), net | -5.77M | 3.34K | 0 |
Income before tax | -14.42M | -1.39M | -19.36K |
Income tax expense | -164.20K | -3.34K | 0 |
Net income | -14.26M | -1.39M | -19.36K |
Earnings per share | |||
Basic EPS | -3.69 | -0.36 | -0.00 |
Diluted EPS | -3.69 | -0.08 | -0.00 |
| Data source | Data source | Data source |